CCMI
BEAM icon

Creative Capital Management Investments’s Beam Therapeutics BEAM Stock Holding History

Creative Capital Management Investments’s Portfolio BEAM Stock Details BEAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$240 Buy
+7
New +$211 ﹤0.01% 1373

Other funds holding BEAM

DADC
D.A. Davidson & Co Great Falls, Montana $18.1B AUM 24.63% 1-Year Est. Return
PIM
Peregrine Investment Management Toronto, Ontario, Canada $235M AUM 131.85% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
BEI
Benjamin Edwards Inc Clayton, Missouri $11B AUM 18.22% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
YMRC
Yorktown Management & Research Company Forest, Virginia $163M AUM 68.53% 1-Year Est. Return
GITFIT
Generali Investments Towarzystwo Funduszy Inwestycyjnych (TFI) Warsaw, Poland $249M AUM 37.04% 1-Year Est. Return
EWA
EverSource Wealth Advisors Birmingham, Alabama $2.97B AUM 28.74% 1-Year Est. Return
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return
MMA
Miracle Mile Advisors Los Angeles, California $8.53B AUM 21.43% 1-Year Est. Return

Creative Capital Management Investments's BEAM Position: Q2 2026 in Review

Creative Capital Management Investments opened a new position in Beam Therapeutics (BEAM) in Q2 2026: 7 shares worth $240. The stake represents ﹤0.01% of the portfolio and ranks #1373 among its holdings.

37 funds tracked by Wall St. Rank hold BEAM as of Q2 2026.

  • Creative Capital Management Investments held 7 shares of Beam Therapeutics worth $240 as of Q2 2026.
  • Beam Therapeutics was a new Creative Capital Management Investments position in Q2 2026.
  • Beam Therapeutics made up ﹤0.01% of Creative Capital Management Investments's portfolio in Q2 2026, its #1373 holding.
  • 37 funds tracked by Wall St. Rank held Beam Therapeutics as of Q2 2026.

Based on Creative Capital Management Investments's 13F filing for Q2 2026, filed 24 Jul 2026.